Shiau, J.-P.; Wu, C.-C.; Chang, S.-J.; Pan, M.-R.; Liu, W.; Ou-Yang, F.; Chen, F.-M.; Hou, M.-F.; Shih, S.-L.; Luo, C.-W.
FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer. Biomedicines 2021, 9, 1789.
https://doi.org/10.3390/biomedicines9121789
AMA Style
Shiau J-P, Wu C-C, Chang S-J, Pan M-R, Liu W, Ou-Yang F, Chen F-M, Hou M-F, Shih S-L, Luo C-W.
FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer. Biomedicines. 2021; 9(12):1789.
https://doi.org/10.3390/biomedicines9121789
Chicago/Turabian Style
Shiau, Jun-Ping, Cheng-Che Wu, Shu-Jyuan Chang, Mei-Ren Pan, Wangta Liu, Fu Ou-Yang, Fang-Ming Chen, Ming-Feng Hou, Shen-Liang Shih, and Chi-Wen Luo.
2021. "FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer" Biomedicines 9, no. 12: 1789.
https://doi.org/10.3390/biomedicines9121789
APA Style
Shiau, J.-P., Wu, C.-C., Chang, S.-J., Pan, M.-R., Liu, W., Ou-Yang, F., Chen, F.-M., Hou, M.-F., Shih, S.-L., & Luo, C.-W.
(2021). FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer. Biomedicines, 9(12), 1789.
https://doi.org/10.3390/biomedicines9121789
